APO Research
Talk to an analyst

APO RESEARCH · REPORT

Visual Neurosurgery Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Visual Neurosurgery Software Market Outlook and Growth Opportunities 2026

1 May 2026195 pages

Choose your research edition.

Industry ResearchVisual Neurosurgery Software Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Visual Neurosurgery Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Visual Neurosurgery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Visual Neurosurgery Software Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Visual Neurosurgery Software Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Visual Neurosurgery Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Visual Neurosurgery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Visual Neurosurgery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Visual Neurosurgery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Visual Neurosurgery Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Visual Neurosurgery Software market include Shenzhen Hanix United, Olea Medical, MediCAD, Imedis, Brainlab, Advanced Brain Monitoring, Shimmer Research, Advantis Medical Imaging and G.Tec Medical Engineering, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Visual Neurosurgery Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Visual Neurosurgery Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Visual Neurosurgery Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Visual Neurosurgery Software market.

Visual Neurosurgery Software Segment by Company

Shenzhen Hanix United

Olea Medical

MediCAD

Imedis

Brainlab

Advanced Brain Monitoring

Shimmer Research

Advantis Medical Imaging

G.Tec Medical Engineering

ANT Neuro

NordicNeuroLab

Visual Neurosurgery Software Segment by Type

Real-time Processing

Non-real-time Processing

Visual Neurosurgery Software Segment by Application

Preoperative Planning

Intraoperative Monitoring

Surgical Navigation

Others

Visual Neurosurgery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Visual Neurosurgery Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Visual Neurosurgery Software key companies, revenue, market share, and recent developments.

3. To split the Visual Neurosurgery Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Visual Neurosurgery Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Visual Neurosurgery Software significant trends, drivers, influence factors in global and regions.

6. To analyze Visual Neurosurgery Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Visual Neurosurgery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Visual Neurosurgery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Visual Neurosurgery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Visual Neurosurgery Software industry.

Chapter 3: Detailed analysis of Visual Neurosurgery Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Visual Neurosurgery Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Visual Neurosurgery Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Visual Neurosurgery Software Industry Trends Table 2. Visual Neurosurgery Software Industry Drivers Table 3. Visual Neurosurgery Software Industry Opportunities and Challenges Table 4. Visual Neurosurgery Software Industry Restraints Table 5. Global Visual Neurosurgery Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Visual Neurosurgery Software Revenue Share by Company (2021-2026) Table 7. Global Visual Neurosurgery Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Visual Neurosurgery Software Key Company Manufacturing Base & Headquarters Table 9. Global Visual Neurosurgery Software Company, Product Type & Application Table 10. Global Visual Neurosurgery Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Visual Neurosurgery Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Real-time Processing Table 15. Significant Companies of Non-real-time Processing Table 16. Global Visual Neurosurgery Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Visual Neurosurgery Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Visual Neurosurgery Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Visual Neurosurgery Software Sales Value Share by Type (2021-2026) Table 20. Global Visual Neurosurgery Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Preoperative Planning Table 22. Significant Companies of Intraoperative Monitoring Table 23. Significant Companies of Surgical Navigation Table 24. Significant Companies of Others Table 25. Global Visual Neurosurgery Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Visual Neurosurgery Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Visual Neurosurgery Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Visual Neurosurgery Software Sales Value Share by Application (2021-2026) Table 29. Global Visual Neurosurgery Software Sales Value Share by Application (2027-2032) Table 30. Global Visual Neurosurgery Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Visual Neurosurgery Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Visual Neurosurgery Software Sales Value Share by Region (2021-2026) Table 33. Global Visual Neurosurgery Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Visual Neurosurgery Software Sales Value Share by Region (2027-2032) Table 35. Global Visual Neurosurgery Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Visual Neurosurgery Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Visual Neurosurgery Software Sales Value Market Share by Country (2021-2026) Table 38. Global Visual Neurosurgery Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Visual Neurosurgery Software Sales Value Market Share by Country (2027-2032) Table 40. Shenzhen Hanix United Company Information Table 41. Shenzhen Hanix United Business Overview Table 42. Shenzhen Hanix United Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Shenzhen Hanix United Visual Neurosurgery Software Product Portfolio Table 44. Shenzhen Hanix United Recent Development Table 45. Olea Medical Company Information Table 46. Olea Medical Business Overview Table 47. Olea Medical Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Olea Medical Visual Neurosurgery Software Product Portfolio Table 49. Olea Medical Recent Development Table 50. MediCAD Company Information Table 51. MediCAD Business Overview Table 52. MediCAD Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. MediCAD Visual Neurosurgery Software Product Portfolio Table 54. MediCAD Recent Development Table 55. Imedis Company Information Table 56. Imedis Business Overview Table 57. Imedis Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Imedis Visual Neurosurgery Software Product Portfolio Table 59. Imedis Recent Development Table 60. Brainlab Company Information Table 61. Brainlab Business Overview Table 62. Brainlab Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Brainlab Visual Neurosurgery Software Product Portfolio Table 64. Brainlab Recent Development Table 65. Advanced Brain Monitoring Company Information Table 66. Advanced Brain Monitoring Business Overview Table 67. Advanced Brain Monitoring Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Advanced Brain Monitoring Visual Neurosurgery Software Product Portfolio Table 69. Advanced Brain Monitoring Recent Development Table 70. Shimmer Research Company Information Table 71. Shimmer Research Business Overview Table 72. Shimmer Research Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Shimmer Research Visual Neurosurgery Software Product Portfolio Table 74. Shimmer Research Recent Development Table 75. Advantis Medical Imaging Company Information Table 76. Advantis Medical Imaging Business Overview Table 77. Advantis Medical Imaging Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Advantis Medical Imaging Visual Neurosurgery Software Product Portfolio Table 79. Advantis Medical Imaging Recent Development Table 80. G.Tec Medical Engineering Company Information Table 81. G.Tec Medical Engineering Business Overview Table 82. G.Tec Medical Engineering Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. G.Tec Medical Engineering Visual Neurosurgery Software Product Portfolio Table 84. G.Tec Medical Engineering Recent Development Table 85. ANT Neuro Company Information Table 86. ANT Neuro Business Overview Table 87. ANT Neuro Visual Neurosurgery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. ANT Neuro Visual Neurosurgery Software Product Portfolio Table 89. ANT Neuro Recent Development Table 90. NordicNeuroLab Company Information Table 91. NordicNeuroLab Business Overview Table 92. NordicNeuroLab Visual Neurosurgery Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. NordicNeuroLab Visual Neurosurgery Software Product Portfolio Table 94. NordicNeuroLab Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Visual Neurosurgery Software Product Image Figure 2. Global Visual Neurosurgery Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Visual Neurosurgery Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Visual Neurosurgery Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Real-time Processing Image Figure 8. Non-real-time Processing Image Figure 9. Global Visual Neurosurgery Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Visual Neurosurgery Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Visual Neurosurgery Software Sales Value Share by Type (2021-2032) Figure 12. Preoperative Planning Image Figure 13. Intraoperative Monitoring Image Figure 14. Surgical Navigation Image Figure 15. Others Image Figure 16. Global Visual Neurosurgery Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Visual Neurosurgery Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Visual Neurosurgery Software Sales Value Share by Application (2021-2032) Figure 19. Global Visual Neurosurgery Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Visual Neurosurgery Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Visual Neurosurgery Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Visual Neurosurgery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Visual Neurosurgery Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Visual Neurosurgery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Visual Neurosurgery Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Visual Neurosurgery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Visual Neurosurgery Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Visual Neurosurgery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Visual Neurosurgery Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Visual Neurosurgery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Visual Neurosurgery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Real-time Processing
  • Non-real-time Processing
Applications
  • Preoperative Planning
  • Intraoperative Monitoring
  • Surgical Navigation
  • Others
Companies covered
  • Shenzhen Hanix United
  • Olea Medical
  • MediCAD
  • Imedis
  • Brainlab
  • Advanced Brain Monitoring
  • Shimmer Research
  • Advantis Medical Imaging
  • G.Tec Medical Engineering
  • ANT Neuro
  • NordicNeuroLab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Visual Neurosurgery Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Visual Neurosurgery Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Visual Neurosurgery Software Market Dynamics
  1. 2.1 Visual Neurosurgery Software Industry Trends
  2. 2.2 Visual Neurosurgery Software Industry Drivers
  3. 2.3 Visual Neurosurgery Software Industry Opportunities and Challenges
  4. 2.4 Visual Neurosurgery Software Industry Restraints
3 Visual Neurosurgery Software Market by Company
  1. 3.1 Global Visual Neurosurgery Software Company Revenue Ranking in 2025
  2. 3.2 Global Visual Neurosurgery Software Revenue by Company (2021-2026)
  3. 3.3 Global Visual Neurosurgery Software Company Ranking (2024-2026)
  4. 3.4 Global Visual Neurosurgery Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Visual Neurosurgery Software Company Product Type and Application
  6. 3.6 Global Visual Neurosurgery Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Visual Neurosurgery Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Visual Neurosurgery Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Visual Neurosurgery Software Market by Type
  1. 4.1 Visual Neurosurgery Software Type Introduction
  2. 4.1.1 Real-time Processing
  3. 4.1.2 Non-real-time Processing
  4. 4.2 Global Visual Neurosurgery Software Sales Value by Type
  5. 4.2.1 Global Visual Neurosurgery Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Visual Neurosurgery Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Visual Neurosurgery Software Sales Value Share by Type (2021-2032)
5 Visual Neurosurgery Software Market by Application
  1. 5.1 Visual Neurosurgery Software Application Introduction
  2. 5.1.1 Preoperative Planning
  3. 5.1.2 Intraoperative Monitoring
  4. 5.1.3 Surgical Navigation
  5. 5.1.4 Others
  6. 5.2 Global Visual Neurosurgery Software Sales Value by Application
  7. 5.2.1 Global Visual Neurosurgery Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Visual Neurosurgery Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global Visual Neurosurgery Software Sales Value Share by Application (2021-2032)
6 Visual Neurosurgery Software Regional Value Analysis
  1. 6.1 Global Visual Neurosurgery Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Visual Neurosurgery Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Visual Neurosurgery Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Visual Neurosurgery Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Visual Neurosurgery Software Sales Value (2021-2032)
  7. 6.3.2 North America Visual Neurosurgery Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Visual Neurosurgery Software Sales Value (2021-2032)
  10. 6.4.2 Europe Visual Neurosurgery Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Visual Neurosurgery Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Visual Neurosurgery Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Visual Neurosurgery Software Sales Value (2021-2032)
  16. 6.6.2 South America Visual Neurosurgery Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Visual Neurosurgery Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Visual Neurosurgery Software Sales Value Share by Country, 2025 VS 2032
7 Visual Neurosurgery Software Country-level Value Analysis
  1. 7.1 Global Visual Neurosurgery Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Visual Neurosurgery Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Visual Neurosurgery Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Visual Neurosurgery Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Visual Neurosurgery Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Visual Neurosurgery Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Visual Neurosurgery Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Hanix United
  2. 8.1.1 Shenzhen Hanix United Company Information
  3. 8.1.2 Shenzhen Hanix United Business Overview
  4. 8.1.3 Shenzhen Hanix United Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Hanix United Visual Neurosurgery Software Product Portfolio
  6. 8.1.5 Shenzhen Hanix United Recent Developments
  7. 8.2 Olea Medical
  8. 8.2.1 Olea Medical Company Information
  9. 8.2.2 Olea Medical Business Overview
  10. 8.2.3 Olea Medical Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Olea Medical Visual Neurosurgery Software Product Portfolio
  12. 8.2.5 Olea Medical Recent Developments
  13. 8.3 MediCAD
  14. 8.3.1 MediCAD Company Information
  15. 8.3.2 MediCAD Business Overview
  16. 8.3.3 MediCAD Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MediCAD Visual Neurosurgery Software Product Portfolio
  18. 8.3.5 MediCAD Recent Developments
  19. 8.4 Imedis
  20. 8.4.1 Imedis Company Information
  21. 8.4.2 Imedis Business Overview
  22. 8.4.3 Imedis Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Imedis Visual Neurosurgery Software Product Portfolio
  24. 8.4.5 Imedis Recent Developments
  25. 8.5 Brainlab
  26. 8.5.1 Brainlab Company Information
  27. 8.5.2 Brainlab Business Overview
  28. 8.5.3 Brainlab Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Brainlab Visual Neurosurgery Software Product Portfolio
  30. 8.5.5 Brainlab Recent Developments
  31. 8.6 Advanced Brain Monitoring
  32. 8.6.1 Advanced Brain Monitoring Company Information
  33. 8.6.2 Advanced Brain Monitoring Business Overview
  34. 8.6.3 Advanced Brain Monitoring Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Advanced Brain Monitoring Visual Neurosurgery Software Product Portfolio
  36. 8.6.5 Advanced Brain Monitoring Recent Developments
  37. 8.7 Shimmer Research
  38. 8.7.1 Shimmer Research Company Information
  39. 8.7.2 Shimmer Research Business Overview
  40. 8.7.3 Shimmer Research Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shimmer Research Visual Neurosurgery Software Product Portfolio
  42. 8.7.5 Shimmer Research Recent Developments
  43. 8.8 Advantis Medical Imaging
  44. 8.8.1 Advantis Medical Imaging Company Information
  45. 8.8.2 Advantis Medical Imaging Business Overview
  46. 8.8.3 Advantis Medical Imaging Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Advantis Medical Imaging Visual Neurosurgery Software Product Portfolio
  48. 8.8.5 Advantis Medical Imaging Recent Developments
  49. 8.9 G.Tec Medical Engineering
  50. 8.9.1 G.Tec Medical Engineering Company Information
  51. 8.9.2 G.Tec Medical Engineering Business Overview
  52. 8.9.3 G.Tec Medical Engineering Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 G.Tec Medical Engineering Visual Neurosurgery Software Product Portfolio
  54. 8.9.5 G.Tec Medical Engineering Recent Developments
  55. 8.10 ANT Neuro
  56. 8.10.1 ANT Neuro Company Information
  57. 8.10.2 ANT Neuro Business Overview
  58. 8.10.3 ANT Neuro Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ANT Neuro Visual Neurosurgery Software Product Portfolio
  60. 8.10.5 ANT Neuro Recent Developments
  61. 8.11 NordicNeuroLab
  62. 8.11.1 NordicNeuroLab Company Information
  63. 8.11.2 NordicNeuroLab Business Overview
  64. 8.11.3 NordicNeuroLab Visual Neurosurgery Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NordicNeuroLab Visual Neurosurgery Software Product Portfolio
  66. 8.11.5 NordicNeuroLab Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst